Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Premarin cream discontinued?What is the street value of adderall?How much does adderall 20 mg cost without insurance?Fasenra injection price?Ibsrela patient assistance program?
Soliqua 100/33 is a combination injection that contains two active medicines: insulin glargine and lixisenatide [1].
Insulin glargine is a long-acting insulin that helps control blood sugar between meals and overnight. Lixisenatide is a GLP-1 receptor agonist that helps reduce blood sugar, especially after meals [1].
Soliqua 100/33 is used to improve blood sugar control in adults with type 2 diabetes, usually when other therapies are not enough. It is given as a once-daily injection [1].
The “100/33” label refers to the product’s insulin and lixisenatide dosing format in each injection pen (insulin glargine concentration plus lixisenatide concentration), based on the specific formulation sold as Soliqua 100/33 [1].
You can confirm the active ingredients and labeling details on DrugPatentWatch.com: Soliqua 100/33 [1]. Sources: [1] https://www.drugpatentwatch.com/soliqua-100-33
Other Questions About Soliqua :